Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Akihiro Iwata"'
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Objectives Although guidelines recommend antiviral therapy for outpatients with COVID-19 who are at high risk of progressing to severe conditions, such as older adults, many patients do not receive appropriate treatment. Little is known, however, abo
Externí odkaz:
https://doaj.org/article/6218773bfeb3420c9568d756786df522
Autor:
Yutaka Ota, Shinya Yoshizawa, Katsuya Sakai, Yoshinori Ueda, Masaya Takashima, Koji Kagawa, Akihiro Iwata
Publikováno v:
IATSS Research, Vol 47, Iss 2, Pp 270-276 (2023)
This paper summarizes current trends in the research and development of e-Mobility and energy coupled simulation to deal with electric vehicle integration into power systems, optimal charging infrastructure design, and regional energy and environment
Externí odkaz:
https://doaj.org/article/34589df1df6c4544a62723fe9accfeae
Autor:
Tomoki Chatani, Taiichi Shikama, Yohei Ueno, Shinichiro Kado, Hayato Kawazome, Takashi Minami, Ryota Matoike, Minato Murakumo, Shinji Kobayashi, Shinsuke Ohshima, Akihiro Iwata, Tetsutaro Oishi, Akihiro Ishizawa, Yuji Nakamura, Hiroyuki Okada, Shigeru Konoshima, Tohru Mizuuchi, Kazunobu Nagasaki, Masahiro Hasuo
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract For plasma spectroscopy, Stokes spectropolarimetry is used as a method to spatially invert the viewing-chord-integrated spectrum on the basis of the correspondence between the given magnetic field profile along the viewing chord and the Zeem
Externí odkaz:
https://doaj.org/article/4d9514e1d0614022a2d9a05541ee5664
Autor:
Hisashi Kawata, Makoto Aihara, Noriko Odani-Kawabata, Fenghe Lu, Akihiro Iwata, Naveed K Shams
Publikováno v:
American Journal of Ophthalmology. 220:53-63
Purpose To evaluate the efficacy and safety of omidenepag isopropyl (OMDI), a selective, non-prostaglandin, prostanoid EP2 receptor agonist, in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Design Phase III,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::615c1c847eac80b5c72a17ffb92ab991
https://doi.org/10.1016/j.ajo.2020.06.003
https://doi.org/10.1016/j.ajo.2020.06.003
Autor:
Makoto, Aihara, Fenghe, Lu, Hisashi, Kawata, Akihiro, Iwata, Noriko, Odani-Kawabata, Naveed K, Shams
Publikováno v:
American journal of ophthalmology. 220
To evaluate the efficacy and safety of omidenepag isopropyl (OMDI), a selective, non-prostaglandin, prostanoid EP2 receptor agonist, in Japanese patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT).Phase III, randomized, inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cc9527817e02b140f6b5f5efb65a4e7
https://pubmed.ncbi.nlm.nih.gov/34462073
https://pubmed.ncbi.nlm.nih.gov/34462073
Autor:
Akihiro Iwata, Hisashi Kawata, Auli Ropo, Fenghe Lu, Makoto Aihara, Noriko Odani-Kawabata, Naveed K Shams
Publikováno v:
Japanese journal of ophthalmology. 64(4)
Omidenepag isopropyl (OMDI) is the prodrug of omidenepag, a selective, non-prostaglandin, prostanoid EP2 receptor agonist, which has been shown to lower intraocular pressure (IOP) in patients with glaucoma and ocular hypertension (OHT). This study ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51fd1e4bc08bd44908d4f6dfeb2178e7
https://pubmed.ncbi.nlm.nih.gov/32572719
https://pubmed.ncbi.nlm.nih.gov/32572719
Autor:
Noriko Odani-Kawabata, Makoto Aihara, Fenghe Lu, Akihiro Iwata, Hisashi Kawata, Naveed K Shams, Kathy Liu
Publikováno v:
Journal of glaucoma. 28(5)
PRéCIS:: Three randomized, multicenter studies demonstrated the stable intraocular pressure-lowering effects and tolerability of omidenepag isopropyl in patients with primary open-angle glaucoma and ocular hypertension; 0.002% was identified as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd6bd73996a82d7a3bf3eec23c32d3f4
https://pubmed.ncbi.nlm.nih.gov/30839416
https://pubmed.ncbi.nlm.nih.gov/30839416
Autor:
Akihiro Iwata
Publikováno v:
Journal of the Japan Society for Precision Engineering. 79:392-396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2378b3ba430f2f5383c4c32ede43e1f0
https://doi.org/10.2493/jjspe.79.392
https://doi.org/10.2493/jjspe.79.392
Autor:
Hideki Miyake, Masatsugu Nakamura, Hiroshi Tanaka, Akihiro Iwata, Yuri Kawano, Takahiro Imanaka
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Hideki Miyake,1 Yuri Kawano,2 Hiroshi Tanaka,2 Akihiro Iwata,3 Takahiro Imanaka,1 Masatsugu Nakamura1 1Ophthalmic Disease Area Strategy Department, 2Clinical Operations Department, 3Data Science Department, R&D Division, Santen Pharmaceutical Co., Lt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb7e0869f4181deb12bfb56844499f4
https://www.dovepress.com/tear-volume-estimation-using-a-modified-schirmer-test-a-randomized-mul-peer-reviewed-article-OPTH
https://www.dovepress.com/tear-volume-estimation-using-a-modified-schirmer-test-a-randomized-mul-peer-reviewed-article-OPTH
Publikováno v:
Drug Information Journal. 45:65-76
We evaluate the probability of observing consistent results and the relationships between the required sample size and the effect size for a confirmatory multiregional trial. Three methods are evaluated, including two methods (methods 1 and 2) alread
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a46a47954fffb13595a87fa40763285e
https://doi.org/10.1177/009286151104500107
https://doi.org/10.1177/009286151104500107